Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Current Leases: 2020-2025

Historic Current Leases for Tango Therapeutics (TNGX) over the last 4 years, with Sep 2025 value amounting to $3.1 million.

  • Tango Therapeutics' Current Leases rose 8.35% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 8.35%. This contributed to the annual value of $2.5 million for FY2024, which is 17.87% up from last year.
  • Tango Therapeutics' Current Leases amounted to $3.1 million in Q3 2025, which was up 22.42% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Tango Therapeutics' Current Leases ranged from a high of $3.1 million in Q3 2025 and a low of $629,000 during Q2 2022.
  • For the 3-year period, Tango Therapeutics' Current Leases averaged around $2.4 million, with its median value being $2.5 million (2024).
  • In the last 5 years, Tango Therapeutics' Current Leases dropped by 28.48% in 2022 and then surged by 187.28% in 2023.
  • Tango Therapeutics' Current Leases (Quarterly) stood at $1.5 million in 2021, then rose by 17.76% to $1.8 million in 2022, then climbed by 17.63% to $2.1 million in 2023, then climbed by 17.87% to $2.5 million in 2024, then increased by 8.35% to $3.1 million in 2025.
  • Its Current Leases was $3.1 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.8 million in Q1 2025.